Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01334944 · ClinicalTrials.gov registry record · Phase 4
Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
A Phase 4 study of Pain and Fever, sponsored by Cumberland Pharmaceuticals.
- Completed
- Registry status
- Phase 4
- Development phase
- 150
- Enrollment target
- 13
- Study locations
NCT01334944: Completed Phase 4 study of Pain and Fever, sponsored by Cumberland Pharmaceuticals.
NCT01334944 is a Phase 4 study of Pain and Fever that has completed, run by Cumberland Pharmaceuticals. The registered enrollment target is 150 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (51% lower). The trial reports 13 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01334944, a Phase 4 study of Pain and Fever, has completed, sponsored by Cumberland Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 150 participants
- Enrollment target
- 13
- Study locations
Study Summary
The primary objective of this study is to determine the safety of a single dose of intravenous ibuprofen administered over 5-10 minutes for the treatment of fever or pain in the hospital setting.
Primary Outcome
The incidence of treatment-emergent serious adverse events occurring in the six hours following administration of the last dose of intravenous ibuprofen
Interventions
- DRUG Intravenous ibuprofen
Study Locations (13)
North Carolina
- The University of North Carolina Hospitals - Chapel Hill
- Duke University Medical Center - Durham
- The Moses H. Cone Memorial Hospital - Greensboro
- Wake Forest University Baptist Medical Center - Winston-Salem
Ohio
- Fairview - Cleveland
- The Ohio State University Medical Center - Columbus
California
- UCSD - San Diego
Connecticut
- Danbury - Danbury
Florida
- University of Miami - Miller School of Medicine - Miami
Georgia
- Grady - Atlanta
Massachusetts
- Beth Israel Deaconnes MC - Boston
New York
- Columbia - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2011-06 |
| Est. Completion | 2012-10 |
| Phase | Phase 4 |
What the finished NCT01334944 record still lists
NCT01334944 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 304-participant average among 374 other Pain trials with a reported enrollment target (51% lower).
The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Intravenous ibuprofen is the first listed.
NCT01334944 lists 13 locations in 9 states (North Carolina, Ohio, California).
Frequently Asked Questions
What is clinical trial NCT01334944 about?
NCT01334944 is a clinical study titled "Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen". The primary objective of this study is to determine the safety of a single dose of intravenous ibuprofen administered over 5-10 minutes for the treatment of fever or pain in the hospital setting.
What is the current status of trial NCT01334944?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2011-06. Estimated completion is 2012-10.
What conditions does trial NCT01334944 study?
This clinical trial studies the following conditions: Pain, Fever.
What interventions are being tested in trial NCT01334944?
The interventions under investigation include: Intravenous ibuprofen (DRUG).
Who is sponsoring clinical trial NCT01334944?
This trial is sponsored by Cumberland Pharmaceuticals, which has 43 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01334944 being conducted?
This trial has 13 study locations across California, Connecticut, Florida, Georgia, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01334944's enrollment target sits among peer trials
150 114th of 374 higher than 255 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Magnesium on Neuromonitoring
RECRUITING · Phase 4
-
Low-Dose Ketamine Infusion During Burn Wound Care
RECRUITING · Phase 4
-
Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery
RECRUITING · Phase 4
-
Optimizing Pain Control in Transurethral Resection of the Prostate
RECRUITING · Phase 4
-
Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia
RECRUITING · Phase 4
-
Regional Blocks for Lateral Condyle Fractures
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia